Industry news
- Industry news
- Financial Results
News of the day
Market Update
September 01, 2010 -- Nufarm Limited announced today that preliminary and unaudited analysis of 2010 year end results confirms that the net operating profit for the company will be within the $55 million - $65 million range indicated by management in its July 14 market update. moreFinancial Results for The First Half Of 2010: Programs On Track, Decrease In Operating Loss, Controlled Burn Rate And Strong Cash Position
Marseilles, France, August 31, 2010 --Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) announces today its financial results for the first half of 2010. moreMonsanto Projects Solid Conclusion of Fiscal Year
ST. LOUIS, August 31, 2010 -- As its fiscal year draws to a close, Monsanto Company (NYSE: MON) today confirmed the drivers of its fourth-quarter operating plan have tracked well with management expectations, positioning the company to conclude the fiscal year within its previous guidance ranges for ongoing earnings per share (EPS) and free cash flow. moreIndustry news search
Most Viewed
Preliminary Final Report for the year ended 30 June 2010
Monsanto Projects Solid Conclusion of Fiscal Year
Hana Biosciences Reports Second Quarter 2010 Financial Results
Recent news
To keep up to date with news from this category use our 
Pacgen Reports First Quarter Financial Results
Vancouver, BC, Canada (August 30, 2010) - Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX-V: PGA) reported financial results from its first quarter ended June 30, 2010 ("Q1 2011"). Unless...
Financial Results H1 2010
August 30, 2010 -- During the first semester of 2010, turmoil was created in the Greek pharmaceutical market, in anticipation of price reductions which were announced by the government at the beginning of the year...
Preliminary Final Report for the year ended 30 June 2010
27 August 2010 - Sydney, Australia, Auckland, New Zealand- Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) , a global company pioneering the development of cell implants to treat diabetes, announced today...
MESOBLAST FINANCIAL YEAR END RESULTS
Melbourne, Australia; 26 August 2010: Australia's regenerative medicine company, Mesoblast Limited (ASX: MSB; USOTC: MBLTY), today reported its results for the year ended 30 June 2010.
EntreMed Reports Second Quarter 2010 Financial Results
ROCKVILLE, MD - August 16, 2010 - EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and...
Hana Biosciences Reports Second Quarter 2010 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug 13, 2010 -- Hana Biosciences Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and...
NuSep Investor Presentations
AUSTRALIA - 5th August 2010 - NuSep (ASX: NSP) wishes to advise the market that it will hold two investor presentations on 17th and 18th August 2010. These presentations will address the full year results, the...
Alphatec Spine Announces Second Quarter 2010 Revenue and Financial Results
Aug 5, 2010 -- CARLSBAD, Calif., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and...
XenoPort Reports Second Quarter Financial Results
SANTA CLARA, Calif., Aug 05, 2010 -- XenoPort, Inc. (Nasdaq:XNPT) announced today financial results for the second quarter and six months ended June 30, 2010. Revenues for the second quarter were $0.5 million,...
Vanda Pharmaceuticals Reports Second Quarter 2010 Results
ROCKVILLE, Md., Aug 05, 2010--Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today...
Allos Therapeutics Reports Second Quarter 2010 Financial Results
WESTMINSTER, Colo., Jul 28, 2010 --Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported its financial results and business highlights for the quarter and six months ended June 30, 2010.
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us